G3 Global Berhad Past Earnings Performance
Past criteria checks 2/6
G3 Global Berhad has been growing earnings at an average annual rate of 16.9%, while the Healthcare industry saw earnings growing at 24.4% annually. Revenues have been growing at an average rate of 32.5% per year. G3 Global Berhad's return on equity is 2.7%, and it has net margins of 2.5%.
Key information
16.9%
Earnings growth rate
25.3%
EPS growth rate
Healthcare Industry Growth | 31.5% |
Revenue growth rate | 32.5% |
Return on equity | 2.7% |
Net Margin | 2.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Returns Are Gaining Momentum At G3 Global Berhad (KLSE:G3)
Apr 15Is G3 Global Berhad (KLSE:G3) In A Good Position To Invest In Growth?
Sep 02G3 Global Berhad (KLSE:G3) Is In A Good Position To Deliver On Growth Plans
May 13Companies Like G3 Global Berhad (KLSE:G3) Are In A Position To Invest In Growth
Dec 03We're Not Very Worried About G3 Global Berhad's (KLSE:G3) Cash Burn Rate
Apr 06We Think G3 Global Berhad (KLSE:G3) Can Afford To Drive Business Growth
Oct 20Is G3 Global Berhad (KLSE:G3) In A Good Position To Deliver On Growth Plans?
Jul 07How Much Of G3 Global Berhad (KLSE:G3) Do Insiders Own?
Mar 07Shareholders of G3 Global Berhad (KLSE:G3) Must Be Delighted With Their 980% Total Return
Jan 13Revenue & Expenses BreakdownBeta
How G3 Global Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 74 | 2 | 0 | 0 |
30 Sep 23 | 37 | -1 | 5 | 0 |
30 Jun 23 | 35 | -5 | 5 | 0 |
31 Mar 23 | 16 | -8 | 5 | 0 |
31 Dec 22 | 13 | -9 | 5 | 0 |
30 Sep 22 | 31 | -12 | 6 | 0 |
30 Jun 22 | 32 | -14 | 6 | 0 |
31 Mar 22 | 32 | -12 | 6 | 0 |
31 Dec 21 | 24 | -11 | 6 | 0 |
30 Sep 21 | 7 | -11 | 10 | 0 |
30 Jun 21 | 7 | -10 | 10 | 0 |
31 Mar 21 | 9 | -11 | 10 | 0 |
31 Dec 20 | 15 | -13 | 10 | 0 |
30 Sep 20 | 5 | -12 | 12 | 0 |
30 Jun 20 | 9 | -14 | 12 | 0 |
31 Mar 20 | 15 | -15 | 12 | 0 |
31 Dec 19 | 14 | -15 | 12 | 0 |
30 Sep 19 | 14 | -11 | 8 | 0 |
30 Jun 19 | 11 | -10 | 8 | 0 |
31 Mar 19 | 15 | -10 | 8 | 0 |
31 Dec 18 | 13 | -11 | 8 | 0 |
31 Dec 17 | 22 | -9 | 18 | 0 |
31 Oct 17 | 24 | -7 | 0 | 0 |
31 Jul 17 | 27 | -6 | 0 | 0 |
30 Apr 17 | 37 | -11 | 15 | 0 |
31 Jan 17 | 37 | -14 | 15 | 0 |
31 Oct 16 | 37 | -14 | 15 | 0 |
31 Jul 16 | 37 | -14 | 15 | 0 |
30 Apr 16 | 28 | -11 | 17 | 0 |
31 Jan 16 | 29 | -8 | 17 | 0 |
31 Oct 15 | 33 | -11 | 17 | 0 |
31 Jul 15 | 35 | -10 | 17 | 0 |
30 Apr 15 | 36 | -14 | 19 | 0 |
31 Jan 15 | 35 | -13 | 19 | 0 |
31 Oct 14 | 34 | -9 | 19 | 0 |
31 Jul 14 | 36 | -9 | 19 | 0 |
30 Apr 14 | 39 | -4 | 19 | 0 |
31 Jan 14 | 41 | -2 | 19 | 0 |
31 Oct 13 | 42 | -1 | 19 | 0 |
31 Jul 13 | 46 | 1 | 19 | 0 |
Quality Earnings: G3 has a high level of non-cash earnings.
Growing Profit Margin: G3 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: G3 has become profitable over the past 5 years, growing earnings by 16.9% per year.
Accelerating Growth: G3 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: G3 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-2.9%).
Return on Equity
High ROE: G3's Return on Equity (2.7%) is considered low.